and Ferrell S. Ryan of Reid Provident Labs in Atlanta, Georgia decided to merge their two similar sized and complementary companies, calling the new company Reid-Rowell, Inc. Ted Rowell Jr. was made chairman of the board, and Ferrell was made CEO. The combined company employed 380 people, which included a 140-man sales force. Due to management's dedication to the employees, no jobs were lost through the merger process. Reid-Provident was a publicly traded company, but traded on the pink sheets. Now due to the new company's revenues and assets, its stock now qualified it to be traded on the NASDAQ exchange. Since this was late in the 1985 fiscal year, only a portion of the Rowell revenues, from the date of the merger onto the end of the fiscal year, would contribute to the revenues of the overall company for the fiscal year, but the combined annual revenue for the two companies for fiscal 1985 was $32 million. The first quarter of fiscal year 1986 resulted in revenue for Reid-Rowell, Inc. of $10 million for the quarter, and revenue estimates for fiscal 1986 were upwards of $50 million. Sale to Solvay & Cie In 1986, Solvay & Cie of Belgium tendered an offer to purchase the stock of Reid-Rowell, Inc., which was accepted by its board of directors. The company was then purchased by Solvay, became a wholly owned subsidiary, and is today known as Solvay Pharmaceuticals, Inc. Ted Rowell served on the board of directors of Reid-Rowell, the Solvay subsidiary, until 1991. Today, the company reports revenues in excess of $1 billion. More recently, Ted Jr. has been an advisor to the University of Florida School of Pharmacy, and sits on the board of directors of Astralis Group. He continues his involvement in pharmaceutical and entrepreneurial activities as an advisor to Rowell Capital Partners, an investment banking group specializing in opportunities in the pharmaceutical industry and acquisitions in pharmaceutical manufacturing. Rowell Laboratories, Inc., a Florida corporation, was incorporated in 2008 in Orlando, Florida as a separate and new company, and manufactures and sells natural antifungal and natural antibiotic skin care products under the NatureCare brand. Although founded by members of the Rowell family, it is not part of the original Rowell Laboratories, Inc. or Solvay Pharmaceuticals, Inc. of Marietta, Georgia or Brussels, Belgium. On or around Sept. 28, 2009, the global chemical giant Solvay SA of Brussels, Belgium announced